T2D patients have increased plasma concentrations of inflammatory biomarkers such as TNF-α, IL-1β, IL-6, MCP-1, VCAM-1, ICAM-1 and PECAM-1, which are key components of the inflammatory signaling system [29–32]. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.